Metolazon

Gefahreninformationscode (GHS)

• Bildanzeige (GHS)

  

• Alarmwort

  Warnung

• Gefahrenhinweise

  H315：Verursacht Hautreizungen.

  H319：Verursacht schwere Augenreizung.

  H335：Kann die Atemwege reizen.

• Sicherheit

  P264：Nach Gebrauch gründlich waschen.

  P264：Nach Gebrauch gründlich waschen.

  P280：Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.

  P302+P352：BEI BERÜHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckmäßig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen.

  P305+P351+P338：BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

  P321：Besondere Behandlung

  P332+P313：Bei Hautreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

  P362：Kontaminierte Kleidung ausziehen und vor erneutem Tragen waschen.

Metolazone Chemische Eigenschaften,Einsatz,Produktion Methoden

• Beschreibung

  Metolazone (Item No. 26304) is an analytical reference standard categorized as a diuretic. It has been detected as an adverse analytical finding (AAF) during anti-doping testing. This product is intended for use in analytical forensic applications. This product is also available as a general research tool .

• Chemische Eigenschaften

  Crystalline Solid

• Originator

  Zaroxolyn,Pennwalt,UK,1973

• Verwenden

  diuretic, antihypertensive

• Verwenden

  Metolazone acts on the distal tubules, thus increasing excretion of water and sodium, potassium, and chloride ions. It is used for treating edema caused by cardiac insufficiency and adrenal irregularities, including nephrotic syndrome.

• Verwenden

  A diruetic. An antihypertensive

• Definition

  ChEBI: A quinazoline that consists of 1,2,3,4-tetrahydroquinazolin-4-one bearing additional methyl, 2-tolyl, sulfamyl and chloro substituents at positions 2, 3, 6 and 7 respectively. A quinazoline diuretic, with properties similar to thiazide diuretics.

• Manufacturing Process

  Preparation of Intermediate Compound N-Acetyl-5-Chloro-2-Methylaniline: To a well-stirred mixture of 1,270 g (9 mols) of 5-chloro-2-methylaniline in 7.5 liters of water at 34°C was added all at once 1,710 ml (18 mols) of acetic anhydride. A solution was obtained and then almost immediately the product started to crystallize. The temperature rose to 60°C. The mixture was stirred until the temperature dropped to 30°C. The product was filtered and washed well with water. Yield 97% (1,640 g), MP 134° to 138°C. Product was air dried and then in vacuum over P2O5.
  Preparation of Intermediate Compound 5-Chloro-2-Methyl-4- Sulfamylacetanilide: Into a 3-necked 3-liter flask fitted with stirrer and thermometer 540 ml of chlorosulfonic acid were placed and cooled in an ice bath to 20°C. 300 g of the acetanilide were added portionwise while stirring and maintaining temperature at 20°C. This addition takes approximately 20 minutes. Remove the ice bath and add 88 g of sodium chloride portionwise (approximately 1 tsp every 10 minutes), This addition takes approximately 1 hour. Some foaming takes place. Using heating mantle bring temperature up slowly (approximately ? hour) to 75°C. Considerable foaming takes place and heating is continued another ? hour until 92°C is reached. Foaming can be controlled by shutting off heat and with good stirring. Once the temperature of 92°C has been reached and foaming has subsided reaction can be left unattended. Keep reaction at 92°C for a total of 2? hours.
  Pour the hot reaction mixture onto 4 liters of crushed ice. Pour slowly and stir the ice mixture. What remains in the flask can be worked up by adding ice to it and swirling the contents. After approximately 3/4 of an hour, the solid is filtered and washed with approximately 600 ml water.
  Break up cake into small pieces and add to 2.5 liters concentrated NH4OH in 4 liter beaker. Stir. Solid goes into solution and then the sulfonamide precipitates out. Heat to 50°C and then turn off heat. After ? hour cool in ice bath and filter. Wash cake with 600 ml water. Add cake to 2 liters 5% NaOH (130 ml 50% NaOH to 2 liters water). Filter and discard insolubles. While cooling filtrate add concentrated HCl until mixture is acid. Filter and wash cake until filtrate is neutral. Suck cake as dry as possible then air dry. Yield approximately 200 g (45%), MP 255° to 260°C.
  Preparation of Intermediate Compound 4-Chloro-5-Sulfamyl-NAcetylanthranilic Acid: To a hot solution (80°C) of 366 g (1.482 mols) of magnesium sulfate (Epsom salts) in 2.8 liters of water was added 130 g (0.495 mol) of powdered 5-chloro-2-methyl-4-sulfamylacetanilide. With stirring and maintaining the temperature at 83°C, 234 g (1.482 mols) of potassium permanganate was added portionwise over a period of 2 hours. The mixture was then kept at 85°C with stirring for an additional 3 hours. By thistime the pink color of the permanganate had been discharged.
  The mixture was cooled to 65°C and 250 g (2.0 mols) of sodium carbonate monohydrate was added. The warm reaction mixture was filtered and the cake washed with water. The filtrate was then slowly treated with concentrated hydrochloric acid until mixture tested acid. Product was then filtered, washed with water and dried. Yield 103 g (71.0%), MP 245° to 249°C (dec.).
  Preparation of Intermediate Compound 2-Methyl-3-o-Tolyl-6-Sulfamyl-7- Chloro-4(3H)-Quinazolinone: Set up a 5-liter 3-necked flask fitted with a stirrer, condenser and a drying tube. To a stirred mixture of 100 g (0.342 mol) of powdered 4-chloro-5-sulfamyl-N-acetylanthranilic acid, 40.2 g (0.376 mol) of o-toluidine and 2.0 liters of dry toluene was added dropwise, over a period of 15 minutes, 21.7 ml (34.1 g) (0.248 mol) of phosphorus trichloride. The mixture was then refluxed for 10 hours. The solid turned somewhat gummy towards the latter part of the first hour. The mixture then became more free flowing as heating was continued. Let stand overnight. The yellow solid

• Trademarks

  Diulo (Searle); Mykrox (UCB); Zaroxolyn(UCB).

• Therapeutic Function

  Diuretic

• Biochem/physiol Actions

  Inhibitor of thiazide-sensitive Na+-Cl- cotransporter; antihypertensive; moderate "loop" diuretic.

• Synthese

  Metolazone, 7-chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinsulfonamide (21.3.20), is synthesized from 5-chloro-2-methylaniline. The amino group is acylated by ethyl chloroformate, forming 5-chloro-N-ethoxycarbonyl-2-methylaniline (21.3.15). The product, upon subsequent reaction with chlorosulfonic acid and ammonia, is transformed in the usual manner into 4-sulfonamido-5-chloro-N-ethoxycarbonyl-2-methylaniline (21.3.16). The methyl group of this product is oxidized by potassium permanganate, giving 5-sulfonamido-4-chloro-N-ethoxycarbonyl anthranylic acid (21.3.17). Upon treating this with thionyl chloride it cycles into the corresponding anhydride (21.3.18). This reacts with o-toluidine, turning it into 2-amino-5-aminosulfonyl-4-chloro-o-toluolbenzamide (21.3.19). Finally, reacting this with dimethylacetal acetic acid gives metolazone (21.3.20).

  

• Einzelnachweise

  Ito et al. (2021), Metolazone upregulates mitochondrial chaperones and extends lifespan in Caenorhabditis elegans; Biogerontology, 22 119 Beaumont et al. (1988), Thiazide diuretic drug receptors in rat kidney: identification with [3H] metolazone; Proc. Natl. Acad. Sci. USA, 85 2311 Moreno et al. (2006), Affinity-defining domains in the Na-Cl cotransporter: a different location for Cl- and thiazide binding; J. Biol. Chem., 281 17266 Temperini et al. (2008), Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct; Bioorg. Med. Chem. Lett., 18 2567

Metolazone Upstream-Materialien And Downstream Produkte

Metolazon Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(168)Suppliers

17560-51-9, Metolazone Verwandte Suche: